Dexamethasone-induced inhibition of miR-132 via methylation promotes TGF-β-driven progression of pancreatic cancer

Mostrar otras versiones (1)

Glucocorticoids (GCs) such as dexamethasone (DEX) are administered as cancer co-treatment for palliative purposes due to their pro-apoptotic effects in lymphoid cancer and limited side effects associated with cancer growth and chemotherapy. However, there is emerging evidence that GCs induce therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Abukiwan, Alia, Nwaeburu, Clifford C., Bauer, Nathalie, Zhao, Zhefu, Liu, Li, Gladkich, Jury, Gross, Wolfgang, Benner, Axel, Strobel, Oliver, Fellenberg, Jörg, Herr, Ingrid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255064/
https://www.ncbi.nlm.nih.gov/pubmed/30387838
http://dx.doi.org/10.3892/ijo.2018.4616

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255064/
https://www.ncbi.nlm.nih.gov/pubmed/30387838
http://dx.doi.org/10.3892/ijo.2018.4616

Ejemplares similares